Literature DB >> 10190953

New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia.

S Siena1, G Sammarelli, M G Grimoldi, R Schiavo, A Nozza, M Roncalli, C Mecucci, A Santoro, C Carlo-Stella.   

Abstract

We report a new chromosomal reciprocal translocation t(5;10)(q33;q22) in a 49-year-old man with atypical chronic myeloid leukemia (a-CML) and history of occupational exposure to petroleum products including benzene and other hydrocarbons. The t(5;10) (q33;q22) was found in 94% and 84% of metaphases in peripheral blood and bone marrow cells, respectively. Cytogenetic analysis of single colonies derived from granulocyte-macrophage (CFU-GM), and erythroid (BFU-E) hematopoietic progenitors showed that 88% and 40% of CFU-GM and BFU-E, respectively, had the t(5;10)(q33;q22). In contrast, peripheral blood T-lymphocytes, and cutaneous fibroblasts had normal 46,XY karyotype. Molecular analysis of the t(5;10)(q33;q22) translocation breakpoint is currently underway in order to identify genes located in this region which might provide insights into the pathogenesis of atypical myeloproliferative disorders.

Entities:  

Mesh:

Year:  1999        PMID: 10190953

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  2 in total

1.  Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene.

Authors:  Miki Yamazaki; Chiaki Nakaseko; Masahiro Takeuchi; Shinichi Ozawa; Yasuhiro Ishizuka; Yasuhito Hatanaka; Nagisa Oshima-Hasegawa; Tomoya Muto; Shokichi Tsukamoto; Shio Mitsukawa; Chikako Ohwada; Yusuke Takeda; Naoya Mimura; Tohru Iseki; Motoharu Fukazawa; Emiko Sakaida
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

2.  Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.

Authors:  Danika Di Giacomo; Martina Quintini; Valentina Pierini; Fabrizia Pellanera; Roberta La Starza; Paolo Gorello; Caterina Matteucci; Barbara Crescenzi; Paolo Fabio Fiumara; Marinella Veltroni; Erika Borlenghi; Francesco Albano; Fabio Forghieri; Monica Maccaferri; Francesca Bettelli; Mario Luppi; Antonio Cuneo; Giuseppe Rossi; Cristina Mecucci
Journal:  Ann Hematol       Date:  2021-12-02       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.